Market movement
In 2024, antibiotics: erythromycin and its derivatives: salts thereof trade exhibited significant decline, with global flows reaching $482,973,809 and a three-year compound annual growth rate of +5.4% (five-year: -0.9%). The all-time peak of $1,555,887,323 was recorded in 2004; the current level is 69% below that high-water mark.
Over the 30-year observation window (1995–2024), 48% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is strengthening (+9.5% acceleration).
The World Trade Flows Characterization classifies antibiotics: erythromycin and its derivatives: salts thereof as "One-way trade" in the unclassified price segment, providing additional context for market positioning and competitive dynamics.
